Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

David Johnson; Carmel Hawley; Brenda Rosser; Elaine Beller; Charles Thompson; Robert Fassett; Paolo Ferrari; Stephen MacDonald; Eugenie Pedagogos; Alan Cass

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

David Johnson, Carmel Hawley, Brenda Rosser, Elaine Beller, Charles Thompson, Robert Fassett, Paolo Ferrari, Stephen MacDonald, Eugenie Pedagogos, Alan Cass

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1-7
Number of pages	7
Journal	BMC Nephrology
Volume	9
Issue number	1
Publication status	Published - 2008
Externally published	Yes

Cite this

@article{efc2369b0bd445f89342af42d2336b01,

title = "Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial",

author = "David Johnson and Carmel Hawley and Brenda Rosser and Elaine Beller and Charles Thompson and Robert Fassett and Paolo Ferrari and Stephen MacDonald and Eugenie Pedagogos and Alan Cass",

year = "2008",

language = "English",

volume = "9",

pages = "1--7",

journal = "BMC Nephrology",

issn = "1471-2369",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia

T2 - A randomized controlled trial

AU - Johnson, David

AU - Hawley, Carmel

AU - Rosser, Brenda

AU - Beller, Elaine

AU - Thompson, Charles

AU - Fassett, Robert

AU - Ferrari, Paolo

AU - MacDonald, Stephen

AU - Pedagogos, Eugenie

AU - Cass, Alan

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=50249092167&partnerID=8YFLogxK

M3 - Comment/debate

SN - 1471-2369

VL - 9

SP - 1

EP - 7

JO - BMC Nephrology

JF - BMC Nephrology

IS - 1

ER -

Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: A randomized controlled trial

Other files and links

Cite this